SimTissue® by Lyson: The One-Stop Phantom Solution for Advanced Surgical Simulation
Exhibitor: LYSON MEDICAL TECHNOLOGY
Date: 2026-05-27
Booth No.: N416
At BIO Asia-Taiwan 2026, Lyson Medical Technology is showcasing "All-in-One Minimally Invasive Surgery (MIS) Skills Training System." The booth (Booth No. N416) features a dedicated Live Clinical MIS Simulation Zone, inviting global clinicians and medical device distributors to experience high-fidelity, hands-on surgical training firsthand.
"Minimally invasive thermal ablation (RFA/MWA) is an emerging clinical trend, offering distinct advantages such as being scarless, safe, and allowing for rapid recovery," stated the Co-founder and CEO of Lyson Innovation. "However, mastering these techniques involves a steep learning curve and high clinical risks. Lyson's proprietary SimTissue biomimetic material technology breaks the limitations of traditional silicone models. Beyond basic tactile and needle-puncture feedback, it successfully replicates real-world thermal protein denaturation—including tissue coagulation and carbonization. This allows physicians to repeatedly practice device manipulation and build procedural confidence across diverse pathological phantoms in a 100% safe environment before entering the operating room."
More Exhibitor's Press Release
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities EG BIOMED US INC. / 2026-06-15
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02
- Empowering eCOA to Deliver Flexible and Efficient Digital Solutions MEDIDATA / 2026-06-02
- Save the Date: LabWare Professional Seminar Coming This September! LABWARE TAIWAN CO., LTD. / 2026-05-29
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-05-29
- Top-Tier Laboratory Equipment Expert "Chuan Fu Technology" to Spark Innovation at BIO Asia-Taiwan CHUNG FU TECHNICAL DEVELOPMENT CO., LTD. / 2026-05-27
